Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 09 January 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration (FDA) released new updates to the Bioresearch Monitoring Information System (BMIS) on 9 January. The program is used by FDA to oversee regulated clinical trials.
According to FDA, BMIS "provides controls to ensure that clinical investigators meet the requirements of the relevant statutes and regulations governing FDA-regulated products." This, in turn, supports the bioresearch monitoring (BIMO) program.
The changes to BMIS include:
BIMO inspections are undertaken by field inspectors from the Office of Regulatory Affairs (ORA), while each relevant center (Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, etc) maintains oversight over inspections.
FDA noted in the Federal Register (FR) document that the system is intended to support regulatory or procedural controls to ensure the compliance of all clinical investigations, and to support the effective performance of the BIMO program.
The FR listing also elaborates on the storage and retrieval of documents, document safeguards, notification procedures, access procedures, record contesting procedures, record exemptions and the routine uses of records maintained in the system.
The additions will take effect on 8 February 2012.
Tags: Bioresearch Monitoring Information System, Oversight, BMIS, BIMO, Latest News, clinical trials
Regulatory Focus newsletters
All the biggest regulatory news and happenings.